Skip to main content
. 2021 Nov 23;13(23):5895. doi: 10.3390/cancers13235895

Table 2.

Association between CXCR4, PKC-δ and CD133 and clinicopathological factors.

CXCR-4 PKC-δ CD133
Negative
(18)
Positive
(33)
p Value Negative
(21)
Positive
(30)
p Value Negative
(22)
Positive
(29)
p Value
No. of Patients
Age
≤60 26 12 14 p < 0.14 10 16 p < 0.77 8 18 p < 0.09
>60 25 6 19 11 14 14 11
Gender
Male 29 11 18 p < 0.77 15 14 p < 0.09 14 15 p < 0.56
Female 22 7 15 6 16 8 14
Stage
I–II 24 9 15 p < 0.78 14 10 p < 0.02 * 16 8 p < 0.001 *
III–IV 27 9 18 7 20 6 21
Lymph node Metastasis
Negative 23 15 8 p < 0.001 ** 16 7 p < 0.001 ** 15 8 p < 0.005 **
Positive 28 3 25 5 23 7 21
Histological Grade
Well Differentiated 8 6 2 p < 0.02 * 6 2 p < 0.10 7 1 p < 0.008 **
Moderately Differentiated 19 7 12 7 12 9 10
Poorly Differentiated 24 5 19 8 16 6 18
Location of the Tumours
Tongue 15 8 7 p < 0.42 7 8 p < 0.54 6 9 p < 0.56
Buccal 9 3 6 5 4 4 5
Palate 8 3 5 4 4 4 4
Gingiva 10 2 8 3 7 6 4
Floor of Mouth 9 2 7 2 7 2 7

Negative (0 and 1+ categories) and Positive (2+ and 3+ categories). * Statistically significant, ** Statistically highly significant.